Colgate-Palmolive (NYSE:CL) Stake Increased by Advisors Asset Management Inc.

Advisors Asset Management Inc. grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 22.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 78,474 shares of the company’s stock after purchasing an additional 14,210 shares during the quarter. Advisors Asset Management Inc.’s holdings in Colgate-Palmolive were worth $7,134,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth about $26,000. Centricity Wealth Management LLC bought a new position in Colgate-Palmolive during the fourth quarter worth $27,000. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive in the fourth quarter worth $32,000. Briaud Financial Planning Inc bought a new stake in Colgate-Palmolive during the fourth quarter valued at $32,000. Finally, Wintrust Investments LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter worth about $33,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 1.4 %

Shares of Colgate-Palmolive stock opened at $89.45 on Wednesday. The business has a fifty day simple moving average of $89.13 and a 200-day simple moving average of $94.44. The firm has a market cap of $72.59 billion, a price-to-earnings ratio of 25.41, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business posted $0.87 earnings per share. On average, equities analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CL. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday, March 14th. JPMorgan Chase & Co. upped their price objective on Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a research note on Friday, March 14th. Barclays cut their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $101.72.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.